News & Perspective

Feb 01, 2019

Feb 01, 2019

ASP Scan (Weekly) for Feb 01, 2019

Animal stewardship partnership
Antibiotic pipeline details
New PACCARB members
Decline in UK antibiotics
Superbug bloodstream infections in Greece
Antibiotics and malaria prevention
Promising antifungal candidate
Proposed UN AMR guidance
Proposed UN AMR guidance
Antibiotic use in nursing homes
Novel antibiotic vs C diff
Pharmacist interventions
Antibiotics for asthma attack

Nov 01, 2018

Nov 01, 2018

News Scan for Nov 01, 2018

More adenovirus in NJ
Antibiotic prescribing in Ontario
H5N6 avian flu death
Farmer's market food safety
New York measles outbreak
US healthcare-related infections

Aug 10, 2018

Aug 10, 2018

ASP Scan (Weekly) for Aug 10, 2018

Cost of antibiotic resistance
Antibiotic resistance in Australia
New antibiotic for pneumonia, skin infections
Ventilator-associated pneumonia risk factors
Autism and early antibiotic exposure
Stewardship standouts
AMR innovation competition
Phased stewardship strategy
Antibiotic use in the Amazon

Mar 30, 2018

Mar 30, 2018

ASP Scan (Weekly) for Mar 30, 2018

Statewide hospital stewardship
New class of synthetic antibiotics
Candida auris in Europe
Experimental C diff drug
Urine culture and prescribing
MRSA, VRE contact precautions
Resistant Acinetobacter in SE Asia
Infection prevention and antibiotic stewardship
Cornerstones of stewardship
Resistant Acinetobacter in kids
C diff prediction tool
Perceived AMR risk in Germany

Feb 09, 2018

Feb 09, 2018

ASP Scan (Weekly) for Feb 09, 2018

Research agenda for antibiotic resistance
Antibiotics for aspiration pneumonitis
Stewardship in kids' pneumonia
Resistant yaws
Antibiotic-resistant Campylobacter
Antimicrobial prescribing survey
Antibiotic-resistant gonorrhea
Insurers and antibiotic stewardship
Money for drug-resistance threat
Drug-resistant gonorrhea in Americas
MDR-TB treatment

May 10, 2011

May 10, 2011

FDA approves Sanofi's intradermal flu vaccine

(CIDRAP News) – Sanofi Pasteur's intradermal influenza vaccine, which involves a shallow needle prick into the skin instead of deep into muscle tissue, has been approved by the US Food and Drug Administration (FDA), the company announced today.

Oct 31, 2008

Oct 31, 2008

Encouraging results reported for injectable flu drug

(CIDRAP News) – BioCryst Pharmaceuticals Inc. reported encouraging results this week in two phase 2 trials of its injectable antiviral drug, peramivir, a potential new treatment for influenza.

Peramivir is a neuraminidase inhibitor, like the licensed antivirals oseltamivir (Tamiflu), which is taken orally, and zanamivir (Relenza), inhaled as a powder.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Pages

Sort Results By:

 Sort Results By:

Narrow results by:

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»